Eliminate fragmentation and reduce IT risk across clinical sample data systems

Trusted by multiple top pharmas, QuartzBio Sample Intelligence closes the clinical sample data governance gap in your R&D architecture, empowering IT teams with a platform that’s harmonized, vendor-agnostic, and built for enterprise scale.

Show me how View case study

Fragmented sample data creates hidden enterprise risk.

IT teams at global pharmas manage sophisticated enterprise data architectures, but sample data remains a persistent gap.

When you’re grappling with as many as 20+ vendors, systems, and global partners,

Data inconsistencies propagate across downstream systems
Audit readiness becomes reactive, not guaranteed
Integration dependencies become brittle and costly to maintain
Critical sample issues are discovered too late—after downstream impact

Over time, IT inherits a growing burden of maintaining pipelines, scripts, and point-to-point integrations instead of enabling innovation.

What R&D IT teams gain with Sample Intelligence:

Standardize across your entire ecosystem
Automated, vendor-agnostic ingestion ensures all sample data conforms to governed enterprise formats.
Reduce compliance and audit risk
Built-in GxP-aligned governance, audit trails, and traceability across all sample data.
Stabilize your data architecture
Replace brittle point integrations with a scalable, centralized data layer.
Scale without re-architecting
Onboard new vendors and systems without introducing new integration risk or complexity.

If you’re ready to fix data architecture problems at their source and regain freedom to innovate and scale, explore Sample Intelligence.

QuartzBio Sample Intelligence - Automated Unification of Sample Ecosystem

Watch a demo

Case Study: How a top 5 pharma doubled trial capacity and eliminated hidden data loss

“With QuartzBio, we spend 85% less time on sample-related tasks.”
–Top Biopharma

A top 5 pharma discovered that outdated sample ops workflows were putting their pipeline at risk. With QuartzBio, they eliminated fragmented systems and gained full visibility into sample data—accelerating timelines and improving dataset quality.

Standardized APIs and formats across all vendors — no more custom transformation pipelines
90% reduction in data wrangling effort across the portfolio – reducing operational risk
98% reduction in manual data reconciliation effort – improving data integrity
Stronger data governance and interoperability across the enterprise R&D data stack
Ability to support scaling portfolios without continuously re-architecting systems

View Case Study

Harmonize sample data without adding complexity.

Learn how your team can close the governance gap, stop spending time on one-off integrations, and build architecture that scales. Request a 15-minute workflow review.

Identify the biggest data architecture risks in your sample ecosystem:

Schedule 15-min Review

QuartzBio Certifications Security Compliance

QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.